Evolution of the use, effectiveness and safety of bismuth-containing quadruple therapy for Helicobacter pylori infection between 2013 and 2021: results from the European registry on H. pylori management (Hp-EuReg).

Olmedo L, Calvet X, Gené E, Bordin DS, Voynovan I, Castro-Fernandez M, Pabón-Carrasco M, Keco-Huerga A, Perez-Aisa Á, Lucendo AJ, Rodrigo L, Sarsenbaeva AS, Khlinov IB, Fadieienko G, Zaytsev O, Lanas Á, Martínez-Domínguez SJ, Alfaro E, Jonaitis L, Núñez Ó, Pellicano R, Hernández L, Gridnyev O, Kupcinskas J, Gasbarrini A, Boltin D, Niv Y, Babayeva G, Marcos-Pinto R, Tepes B, Venerito M, Papp V, Lerang F, Leja M, Phull PS, Marlicz W, Doulberis M, Smith SM, Milivojevic V, Kunovsky L, Mestrovic A, Matysiak-Budnik T, Simsek H, Cano-Català A, Puig I, Moreira L, Parra P, Nyssen OP, Megraud F, O'Morain C, Gisbert JP, Hp-EuReg investigators*

Open source

DOI: 10.1136/gutjnl-2024-332804
Published: 2024 Dec 10
Container: Gut
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1136/gutjnl-2024-332804,
  title = {Evolution of the use, effectiveness and safety of bismuth-containing quadruple therapy for Helicobacter pylori infection between 2013 and 2021: results from the European registry on H. pylori management (Hp-EuReg).},
  author = {Olmedo L and Calvet X and Gené E and Bordin DS and Voynovan I and Castro-Fernandez M and Pabón-Carrasco M and Keco-Huerga A and Perez-Aisa Á and Lucendo AJ and Rodrigo L and Sarsenbaeva AS and Khlinov IB and Fadieienko G and Zaytsev O and Lanas Á and Martínez-Domínguez SJ and Alfaro E and Jonaitis L and Núñez Ó and Pellicano R and Hernández L and Gridnyev O and Kupcinskas J and Gasbarrini A and Boltin D and Niv Y and Babayeva G and Marcos-Pinto R and Tepes B and Venerito M and Papp V and Lerang F and Leja M and Phull PS and Marlicz W and Doulberis M and Smith SM and Milivojevic V and Kunovsky L and Mestrovic A and Matysiak-Budnik T and Simsek H and Cano-Català A and Puig I and Moreira L and Parra P and Nyssen OP and Megraud F and O'Morain C and Gisbert JP and Hp-EuReg investigators*},
  year = {2024},
  journal = {Gut},
  doi = {10.1136/gutjnl-2024-332804},
  url = {https://doi.org/10.1136/gutjnl-2024-332804}
}

RIS

TY  - JOUR
TI  - Evolution of the use, effectiveness and safety of bismuth-containing quadruple therapy for Helicobacter pylori infection between 2013 and 2021: results from the European registry on H. pylori management (Hp-EuReg).
AU  - Olmedo L
AU  - Calvet X
AU  - Gené E
AU  - Bordin DS
AU  - Voynovan I
AU  - Castro-Fernandez M
AU  - Pabón-Carrasco M
AU  - Keco-Huerga A
AU  - Perez-Aisa Á
AU  - Lucendo AJ
AU  - Rodrigo L
AU  - Sarsenbaeva AS
AU  - Khlinov IB
AU  - Fadieienko G
AU  - Zaytsev O
AU  - Lanas Á
AU  - Martínez-Domínguez SJ
AU  - Alfaro E
AU  - Jonaitis L
AU  - Núñez Ó
AU  - Pellicano R
AU  - Hernández L
AU  - Gridnyev O
AU  - Kupcinskas J
AU  - Gasbarrini A
AU  - Boltin D
AU  - Niv Y
AU  - Babayeva G
AU  - Marcos-Pinto R
AU  - Tepes B
AU  - Venerito M
AU  - Papp V
AU  - Lerang F
AU  - Leja M
AU  - Phull PS
AU  - Marlicz W
AU  - Doulberis M
AU  - Smith SM
AU  - Milivojevic V
AU  - Kunovsky L
AU  - Mestrovic A
AU  - Matysiak-Budnik T
AU  - Simsek H
AU  - Cano-Català A
AU  - Puig I
AU  - Moreira L
AU  - Parra P
AU  - Nyssen OP
AU  - Megraud F
AU  - O'Morain C
AU  - Gisbert JP
AU  - Hp-EuReg investigators*
PY  - 2024
JO  - Gut
DO  - 10.1136/gutjnl-2024-332804
UR  - https://doi.org/10.1136/gutjnl-2024-332804
ER  -

APA

L, O., X, C., E, G., DS, B., I, V., M, C., M, P., A, K., Á, P., AJ, L., L, R., AS, S., IB, K., G, F., O, Z., Á, L., SJ, M., E, A., L, J., Ó, N., R, P., L, H., O, G., J, K., A, G., D, B., Y, N., G, B., R, M., B, T., M, V., V, P., F, L., M, L., PS, P., W, M., M, D., SM, S., V, M., L, K., A, M., T, M., H, S., A, C., I, P., L, M., P, P., OP, N., F, M., C, O., JP, G., & investigators*, H. (2024). Evolution of the use, effectiveness and safety of bismuth-containing quadruple therapy for Helicobacter pylori infection between 2013 and 2021: results from the European registry on H. pylori management (Hp-EuReg).. Gut. https://doi.org/10.1136/gutjnl-2024-332804

Source records

pubmed · retrieved 2026-09-26T13:16:26.756Z